Who Is Kyle Diamantas? FDA Food Chief Likely to Lead Agency After Marty Makary's Exit
The administration is searching for a permanent leader as Diamantas faces questions over drug and device oversight at the FDA.
- On Tuesday, FDA Commissioner Marty Makary resigned from the Department of Health and Human Services, and the Trump administration appointed Kyle Diamantas, previously director of the Human Foods Program, as acting commissioner.
- Diamantas, a key architect of the 2025 Dietary Guidelines for Americans, has also overseen the agency's "Operation Stork Speed," meant to improve infant formula supply safety testing and food labeling reform.
- Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy told the Washington Examiner he hopes Diamantas is "only the acting director for a very short period of time," citing concerns about his lack of medical device and pharmaceutical expertise.
- HHS Secretary Robert F. Kennedy Jr. expressed "full confidence" in Diamantas on Tuesday, stating the search for a permanent commissioner "is already underway and we will move forward with urgency."
- Facing a tough Republican primary reelection bid on Saturday, Cassidy has clashed with the White House over nominations, including the withdrawn candidacy of Casey Means and the pending confirmation of Nicole Saphier.
15 Articles
15 Articles
EDITORIAL: President Trump made the right call at FDA
President Donald Trump deserves real credit for the leadership change at the Food and Drug Administration (FDA). The move put a bookend on an increasingly untenable chapter — and acting Commissioner Kyle Diamantas is the right person to steady the agency. Marty Makary did important work during COVID. He told the truth about natural immunity and school closures amid the leftist capture of the public health establishment. But those skills do not m…
Bill Cassidy says new FDA chief lacks drug and medical device experience
EXCLUSIVE — Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-LA) said the new acting Food and Drug Administration commissioner, Kyle Diamantas, does not have the prerequisite expertise to oversee the agency’s complex medical device and pharmaceutical oversight. President Donald Trump’s first commissioner, Dr. Marty Makary, abruptly resigned from office on Tuesday afternoon following a series of controversies at t…
Coverage Details
Bias Distribution
- 70% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
